Partilhar
Informação da revista
Número
Vol. 41. Núm. 12.Páginas 979-1058 (dezembro 2022)
Original articles
Clinical experience of a cardio-oncology consultation at a tertiary university hospital in Portugal: An observational study
Manuela Fiuza, Andreia Magalhães, Miguel Nobre Menezes, Paula Costa, Leonor Abreu Ribeiro, Catarina Abreu, Raquel Brás, Joana Vieira, ... Fausto J. Pinto
Rev Port Cardiol. 2022;41:979-84
Open access
Original articles
Editorial comment
Cardio-oncology: The future is now!
Miguel Carvalho, Carla Sousa
Rev Port Cardiol. 2022;41:985-6
Open access
Remote versus in-office monitoring for implantable cardioverter defibrillators: Results from a randomized pragmatic controlled study in Portugal
Mário Oliveira, Milene Fernandes, Hipólito Reis, João Primo, Victor Sanfins, Vânia Silva, Pedro Silva Cunha, Mónica Silva, ... on behalf of the PORTLink Study Investigators
Rev Port Cardiol. 2022;41:987-97
Open access
Original articles
Editorial comment
Cardiac device remote monitoring in 2022: Are digital and remote monitoring synonymous with ease and improvement?
Gustavo Rodrigues, Pedro Adragão
Rev Port Cardiol. 2022;41:999-1000
Open access
Association of spontaneous echo contrast with Systemic Immune Inflammation Index in patients with mitral stenosis
Saban Kelesoglu, Deniz Elcık, Iskan Zengin, Ramazan Ozan, Mehmet Tugrul Inanc, Ali Dogan, Abdurrahman Oguzhan, Nihat Kalay
Rev Port Cardiol. 2022;41:1001-8
Open access
Original articles
Editorial comment
Thromboembolic risk in mitral stenosis: Are we underestimating the potential role of inflammation?
Marisa Trabulo
Rev Port Cardiol. 2022;41:1009-10
Open access
Development of deep learning segmentation models for coronary X-ray angiography: Quality assessment by a new global segmentation score and comparison with human performance
Miguel Nobre Menezes, João Lourenço-Silva, Beatriz Silva, Tiago Rodrigues, Ana Rita G. Francisco, Pedro Carrilho Ferreira, Arlindo L. Oliveira, Fausto J. Pinto
Rev Port Cardiol. 2022;41:1011-21
Open access
Original articles
Editorial comment
Machine learning – coming soon to a cath lab near you? Or ‘don’t hold your breath’?
António Miguel Ferreira
Rev Port Cardiol. 2022;41:1023-4
Open access
Secondary mitral regurgitation: Maintaining coherence with the American Society of Echocardiography grading guidelines, which proportionality concept best predicts prognosis in the real world?
João Presume, Pedro Lopes, Pedro Freitas, Francisco Albuquerque, Carla Reis, Eduarda Horta, Liliana Marta, Sara Guerreiro, ... Regina Ribeiras
Rev Port Cardiol. 2022;41:1025-32
Open access
Original articles
Editorial comment
State of the art
Iron metabolism and cardiovascular disease: Basic to translational purviews and therapeutical approach
Mihai Lupu, Diana Tudor, Adriana Filip
Rev Port Cardiol. 2022;41:1037-46
Open access
Case reports
A case of lymphocytic myocarditis in a patient treated with an immune checkpoint inhibitor, a recent class of chemotherapy agents
Tatiana Duarte, Cátia Costa, Sara Gonçalves, Luís Raposo, António Ferreira, Catarina Albuquerque, Nuno Vau, Rui Caria
Rev Port Cardiol. 2022;41:1047-51
Open access
A double-edged sword at the intersection between cancer and cardiovascular disease
Ricardo Ladeiras-Lopes
Rev Port Cardiol. 2022;41:1053-4
Open access
Images in cardiology
Heart failure and pericardial mass leading to diagnosis of a rare hematologic disease
Ignacio Barriuso, Eva Pueo, María Isabel Gil, Diego Fernández-Rodríguez, Dolors Viles, Fernando Worner
Rev Port Cardiol. 2022;41:1055-6
Open access
Acknowledgement reviewers
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.